Here's the live share price of Trident Lifeline along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of Trident Lifeline has gained 23.18% CAGR. Over the past year, the corresponding return has been 15.32%.
Trident Lifeline’s current P/E of 27.88x helps give context to how the market is valuing the stock based on recent earnings and growth expectations.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Trident Lifeline | 3.82 | 2.25 | 2.25 | 13.61 | 15.32 | 33.80 | 23.18 |
| Sun Pharmaceutical Industries | -5.24 | -7.12 | 0.92 | -3.39 | -4.99 | 17.25 | 22.54 |
| Divi's Laboratories | -5.49 | -1.78 | -5.14 | -8.17 | 6.06 | 23.21 | 11.34 |
| Torrent Pharmaceuticals | -0.16 | 6.29 | 13.77 | 16.84 | 25.03 | 36.80 | 24.26 |
| Cipla | -4.29 | -7.25 | -10.27 | -6.23 | -3.38 | 9.66 | 11.16 |
| Lupin | -0.74 | 4.02 | 12.03 | 11.42 | 2.16 | 42.16 | 14.74 |
| Dr. Reddy's Laboratories | -2.34 | -7.90 | -4.32 | -6.49 | -11.94 | 10.87 | 2.52 |
| Mankind Pharma | -3.68 | 1.43 | -11.13 | -18.05 | -16.25 | 15.14 | 8.83 |
| Zydus Lifesciences | -4.39 | -5.80 | -11.20 | -10.27 | -11.88 | 25.50 | 12.20 |
| Alkem Laboratories | 0.75 | 3.98 | 4.79 | 18.38 | 12.29 | 24.33 | 13.48 |
| Aurobindo Pharma | -3.29 | -1.55 | 5.22 | 1.31 | 1.72 | 37.78 | 4.51 |
| Abbott India | -1.97 | -0.43 | -6.73 | -19.08 | 0.04 | 8.01 | 13.12 |
| Laurus Labs | -2.23 | 7.17 | 22.93 | 30.14 | 93.28 | 44.84 | 23.83 |
| Biocon | -0.26 | -3.48 | 5.84 | -3.40 | -1.43 | 14.59 | -3.77 |
| Glenmark Pharmaceuticals | -3.74 | 0.77 | 5.68 | -10.16 | 35.45 | 68.26 | 31.32 |
| GlaxoSmithKline Pharmaceuticals | -2.14 | -8.84 | -14.22 | -26.64 | 14.88 | 21.70 | 9.14 |
| Ipca Laboratories | -2.08 | 4.81 | 16.07 | 2.76 | -3.49 | 20.31 | 7.43 |
| Anthem Biosciences | -4.54 | -11.92 | -20.64 | -15.72 | -15.72 | -5.54 | -3.36 |
| Ajanta Pharma | -5.42 | 1.59 | 11.29 | -0.72 | -6.90 | 31.63 | 18.15 |
| Emcure Pharmaceuticals | 2.63 | 11.84 | 14.79 | 14.78 | 14.60 | 4.75 | 2.83 |
Over the last one year, Trident Lifeline has gained 15.32% compared to peers like Sun Pharmaceutical Industries (-4.99%), Divi's Laboratories (6.06%), Torrent Pharmaceuticals (25.03%). From a 5 year perspective, Trident Lifeline has outperformed peers relative to Sun Pharmaceutical Industries (22.54%) and Divi's Laboratories (11.34%).
| Day | SMA | EMA |
|---|---|---|
| 5 | 296.69 | 300.95 |
| 10 | 306.35 | 301.43 |
| 20 | 299.06 | 301.36 |
| 50 | 303.42 | 300.72 |
| 100 | 296.99 | 296.47 |
| 200 | 282.91 | 286.76 |
In the latest quarter, Trident Lifeline saw a rise in promoter holding to 64.09%, while DII stake decreased to 0.35%, FII holding fell to 7.31%, and public shareholding moved down to 28.24% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Date Time | Announcement |
|---|---|
| Jan 18, 2026, 1:59 AM IST | Trident Lifeline - Statement Of Deviation Or Variation Of Funds Under Regulation 32 Of SEBI (Listing Obligations And Disclosu |
| Jan 18, 2026, 1:44 AM IST | Trident Lifeline - Result- Financial Results For The Quarter And Nine Months Ended 31St December, 2025 |
| Jan 18, 2026, 1:34 AM IST | Trident Lifeline - Board Meeting Outcome for Outcome Of Board Meeting Held On 17.01.2026 |
| Jan 13, 2026, 6:50 PM IST | Trident Lifeline - Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results (Standalone & Conso |
| Jan 07, 2026, 9:06 PM IST | Trident Lifeline - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
Trident Lifeline Ltd. is a Public Limited Listed company incorporated on 09/01/2014 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is L51909GJ2014PLC078227 and registration number is 078227. Currently company belongs to the Industry of Pharmaceuticals. Company's Total Operating Revenue is Rs. 67.80 Cr. and Equity Capital is Rs. 11.50 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Trident Lifeline is ₹306.75 as on Jan 16, 2026.
The Trident Lifeline is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Trident Lifeline is ₹361.90 Cr as on Jan 16, 2026.
Today’s highest and lowest price of Trident Lifeline are ₹306.75 and ₹295.05.
The 52-week high/low is the highest and lowest price at which Trident Lifeline stock has traded in the past 52-week or nearly a year. The 52-week high of Trident Lifeline is ₹328.00 and 52-week low of Trident Lifeline is ₹222.00 as on Jan 16, 2026.
The Trident Lifeline has shown returns of 0.9% over the past day, 2.25% for the past month, 2.25% over 3 months, 15.32% over 1 year, 33.8% across 3 years, and 23.18% over 5 years.
P/E ratio of and PB ratio of Trident Lifeline are 27.88 and 4.82 on Jan 16, 2026. While the company gives a dividend yield of 0.00 per annum.